Home Applications 219876 Application 219876
Type NDA
Sponsor CHIMERIX Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 MODEYSO DORDAVIPRONE HYDROCHLORIDE CAPSULE;ORAL EQ 125MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N219876-001 MODEYSO DORDAVIPRONE HYDROCHLORIDE EQ 125MG BASE CAPSULE / ORAL RLD, RS 2025-08-06
Orange Book patents# Current patent rows page 1 of 1 · 7 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N219876-001 9629842 2032-04-30 U-4254 2025-09-03 N219876-001 RE46290 2032-04-30 U-4254 2025-09-03 N219876-001 9265765 2034-07-26 Drug product 2025-09-03 N219876-001 11976068 2036-03-01 Drug product 2025-09-03 N219876-001 10172862 2037-01-30 U-4254 2025-09-03 N219876-001 10369154 2037-01-30 U-4254 2025-09-03 N219876-001 12102639 2037-01-30 U-4254 2025-09-03
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N219876-001 NCE 2030-08-06 N219876-001 ODE-547 2032-08-06
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N219876-001 MODEYSO EQ 125MG BASE CAPSULE / ORAL RLD, RS 2025-08-06 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N219876-001 MODEYSO EQ 125MG BASE CAPSULE / ORAL RLD, RS 2025-08-06 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219876-001 MODEYSO EQ 125MG BASE CAPSULE / ORAL RLD, RS 2025-08-06 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219876-001 MODEYSO EQ 125MG BASE CAPSULE / ORAL RLD, RS 2025-08-06 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N219876-001 9629842 2032-04-30 U-4254 2025-09-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219876-001 RE46290 2032-04-30 U-4254 2025-09-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219876-001 9265765 2034-07-26 Drug product 2025-09-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219876-001 11976068 2036-03-01 Drug product 2025-09-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219876-001 10172862 2037-01-30 U-4254 2025-09-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219876-001 10369154 2037-01-30 U-4254 2025-09-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219876-001 12102639 2037-01-30 U-4254 2025-09-03 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N219876-001 9629842 2032-04-30 U-4254 2025-09-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219876-001 RE46290 2032-04-30 U-4254 2025-09-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219876-001 9265765 2034-07-26 Drug product 2025-09-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219876-001 11976068 2036-03-01 Drug product 2025-09-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219876-001 10172862 2037-01-30 U-4254 2025-09-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219876-001 10369154 2037-01-30 U-4254 2025-09-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219876-001 12102639 2037-01-30 U-4254 2025-09-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219876-001 9629842 2032-04-30 U-4254 2025-09-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219876-001 RE46290 2032-04-30 U-4254 2025-09-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219876-001 9265765 2034-07-26 Drug product 2025-09-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219876-001 11976068 2036-03-01 Drug product 2025-09-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219876-001 10172862 2037-01-30 U-4254 2025-09-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219876-001 10369154 2037-01-30 U-4254 2025-09-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219876-001 12102639 2037-01-30 U-4254 2025-09-03 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219876-001 9629842 2032-04-30 U-4254 2025-09-03 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219876-001 RE46290 2032-04-30 U-4254 2025-09-03 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219876-001 9265765 2034-07-26 Drug product 2025-09-03 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219876-001 11976068 2036-03-01 Drug product 2025-09-03 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219876-001 10172862 2037-01-30 U-4254 2025-09-03 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219876-001 10369154 2037-01-30 U-4254 2025-09-03 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219876-001 12102639 2037-01-30 U-4254 2025-09-03 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-08-18 06:07:40 2026-07 N219876-001 NCE 2030-08-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219876-001 ODE-547 2032-08-06 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N219876-001 NCE 2030-08-06 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219876-001 NCE 2030-08-06 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219876-001 NCE 2030-08-06 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219876-001 ODE-547 2032-08-06 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join MODEYSO DORDAVIPRONE Jazz Pharmaceuticals, Inc. ad45b43e-fdef-47ad-9c34-055b41bdc576 2026-01-09 Warnings, Adverse reactions Exact identifier application applno (NDA): 219876 application number: NDA219876
Documents# Document, Submission type, Date table Document Submission type Date 83246 ORIG 2025-09-02 83061 ORIG 2025-08-07 83057 ORIG 2025-08-06